Indian startup CrisprBits closed a US$3 million Pre-Series A round led by Spectrum Impact to accelerate development of CRISPR-based diagnostics and R&D capabilities. The funding will support product development, regulatory preparation, and scaling laboratory operations focused on point-of-care and research applications. Founders emphasized leveraging CRISPR detection platforms for rapid, low-cost assays and building a pipeline that spans human diagnostics and sustainable biotech use cases. The round signals investor appetite for regionally based gene-editing diagnostics companies that target local markets and global assay demand.